Treatment with vasopressor medications was associated markedly increased risk for developing intensive care unit (ICU)-associated weakness among critically ill patients on mechanical ventilation, ...
SAN FRANCISCO -- For sepsis-induced hypotension, a restrictive fluid strategy with earlier vasopressor use didn't impact mortality compared with liberal fluids, the CLOVERS trial showed. The ...
Which vasopressors should be given through a central line? Can certain vasopressors be given through a peripheral intravenous (IV) line? Inotropes used intravenously for the treatment of hypotension ...
Gaudry and colleagues sought to determine whether earlier or later initiation of RRT would result in better outcomes in patients who were either mechanically ventilated or on vasopressors (or both) ...
Norepinephrine appears to be a safer choice than epinephrine for patients with cardiogenic shock complicating acute MI, according to results from a randomized trial. Patients given epinephrine were ...
On Medindia find the complete list of Vasopressors drugs with their available forms and strength. More information is available on each drug including their price list. We recommend consulting your ...
Vasopressin is commonly used as an adjunct to catecholamines to support blood pressure in refractory septic shock, but its effect on mortality is unknown. We hypothesized that low-dose vasopressin as ...
DALLAS, Nov. 6, 2022 — The immediate use of veno-arterial mechanical circulatory extracorporeal membrane oxygenation (ECMO) devices to support adults with rapidly deteriorating or severe cardiogenic ...
SAN DIEGO--(BUSINESS WIRE)--La Jolla Pharmaceutical Company (Nasdaq: LJPC) (La Jolla) today announced that results of the ATHOS-3 (Angiotensin II for the Treatment of High-Output Shock) Phase 3 study ...
Hosted on MSN
Windtree Advances Istaroxime Toward Global Phase 3 Following Positive Interim Study Results
WARRINGTON, PA — Windtree Therapeutics, Inc. (NasdaqCM: WINT) has reported encouraging interim results from its ongoing SEISMiC C Phase 2 trial evaluating istaroxime in patients with SCAI Stage C ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results